REQUEST A DEMO
Total
USD $0.00
Search more companies

Polskie Centrum Medycyny Eksperymentalnej Sp. z o.o. (Poland)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Full name: Polskie Centrum Medycyny Eksperymentalnej Sp. z o.o. Profile Updated: October 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Polskie Centrum Medycyny Eksperymentalnej Sp. z o.o. is an enterprise based in Poland. Its main office is in Natolin. It operates in the Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) sector. The enterprise was incorporated on April 28, 2016. A negative growth of 24.09% was recorded in its total assets.

Headquarters
Natolin 15
Natolin; Lodzkie; Postal Code: 92-701

Contact Details: Purchase the Polskie Centrum Medycyny Eksperymentalnej Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Polskie Centrum Medycyny Eksperymentalnej Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Polskie Centrum Medycyny Eksperymentalnej Sp. z o.o. report to view the information.
Incorporation Date:
April 28, 2016
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
80%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Polskie Centrum Medycyny Eksperymentalnej Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
7.24%
Net Profit (Loss) for the Period
7.24%
Total assets
-24.09%
Total equity
-24.01%
Return on Equity (ROE)
-5.72%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?